About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Oncology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Next video in
6
M
Severe Hypoglycemia: What is the Newest Glucagon Treatment? What is the Comparative Efficacy?
By
Michael J. Haller
March 2, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
01:52
Novo Nordisk – GLP-1 RA Therapy
T2D Treatment After Oral Agents: What Is the Next Step?
Feat.
C. Wierum,
L. Coco
Featured Video
11:40
Novo Nordisk – GLP-1 RA Therapy
GLP-1 RA as a First Injectable for T2D: Is It as Effective as Basal Insulin
Feat.
C. Wierum,
L. Coco
Related Content
AUTOPLAY
ON
Scripps Health
2021 Updates in Diabetes Management
Fri, Oct 22, 2021
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a Safer Optio…
08:35
Novo Nordisk – GLP-1 RA Therapy
Reaching A1C Goals With GLP-1 RA Injectables: What Does This Trial Data Sh…
Feat.
R. Pratley
10:02
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combinatio…
Feat.
G. Umpierrez
01:13
Novo Nordisk – GLP-1 RA Therapy
ADA Guidelines for T2D: What Is the Preferred Next Step After Oral Agents?
Feat.
C. Wierum,
L. Coco
13:20
Emory Diabetes Education Training Academy
SMARTDM2: How Will a New Phone Application Simplify Management of T2D?
Feat.
G. Umpierrez
08:59
Novo Nordisk – GLP-1 RA Therapy
GLP-1 RA as a First Injectable: What Is the Safety and Efficacy of Two Dif…
Feat.
R. Pratley
11:29
Robin Conway
Hypoglycemia Classification: What are Important Factors to Consider When D…
26:17
John Tayek
2020 Updates on Insulin Therapy: What Are the Current ADA Standards of Car…
05:50
Mayo Clinic Proceedings
Perioperative Evaluation & Endocrine Disorders: What Are the Medication Ma…
Feat.
C. Himes
11:28
Emory Diabetes Education Training Academy
SGLT-2 Inhibitors And T2D Care: What Is the Mechanism Of Action? What Is t…
Feat.
S. Jacobs
24:39
Philip D. Home
Ultra-Rapid Insulin in Diabetes Care: How Can More Rapidly Absorbed Insuli…
01:52
Novo Nordisk – GLP-1 RA Therapy
T2D Treatment After Oral Agents: What Is the Next Step?
Feat.
C. Wierum,
L. Coco
15:29
Emory Diabetes Education Training Academy
Diabetes Management: Are You Experiencing More Patients Asking About the P…
Feat.
G. Davis
11:13
Viral Shah
The Future of Insulin Therapy in Diabetes: Will Once-A-Week Insulin Inject…
05:36
Cardiometabolic Health Congress (CMHC)
CKD & Diabetes Management: The Role of GLP-1 RAs in Kidney Protection
Feat.
K. R. Tuttle
09:39
Scripps Health
Insulin Delivery Advances: What Are the Benefits of Connected Insulin Pen …
Feat.
D. Ahn
18:18
Cardiometabolic Health Congress (CMHC)
Diabetic Kidney Disease ADA Guidelines for Early Recognition & Screening
Feat.
J. Mcgill
07:20
Cardiometabolic Health Congress (CMHC)
Cardiometabolic Medicine: Does SGLT2i Improve HFrEF Symptoms, QOL, Reduce …
Feat.
K. Ferdinand
14:22
Emory Diabetes Education Training Academy
Insulin Therapy In Patients With T2D Who Fail Oral Anti-Diabetic Agents: W…
Feat.
P. Vellanki
11:31
Domenica Rubino
Weight Loss Maintenance For Adults With Once-Weekly Semaglutide: What Was …
